Association between serum intact parathyroid hormone and survival in dialysis patients.

Chunlei Luo, Xueyan Bian, Chunyang Ji, Hanlu Wang, Jianwei Ma, Chenyu Zhong, Qiang Yu

Abstract read

In one paragraph

Article in International urology and nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chunlei LuoDepartment of Nephrology, The First Affiliated Hospital of Ningbo University, No. 59, Liuting Street, Haishu District, Ningbo, 315000, Zhejiang, China.

Xueyan BianDepartment of Nephrology, The First Affiliated Hospital of Ningbo University, No. 59, Liuting Street, Haishu District, Ningbo, 315000, Zhejiang, China. b875487903@163.com.

Chunyang JiDepartment of Nephrology, The First Affiliated Hospital of Ningbo University, No. 59, Liuting Street, Haishu District, Ningbo, 315000, Zhejiang, China.

Hanlu WangDepartment of Nephrology, The First Affiliated Hospital of Ningbo University, No. 59, Liuting Street, Haishu District, Ningbo, 315000, Zhejiang, China.

Jianwei MaDepartment of Nephrology, The First Affiliated Hospital of Ningbo University, No. 59, Liuting Street, Haishu District, Ningbo, 315000, Zhejiang, China.

Chenyu ZhongDepartment of Nephrology, The First Affiliated Hospital of Ningbo University, No. 59, Liuting Street, Haishu District, Ningbo, 315000, Zhejiang, China.

Qiang YuDepartment of Nephrology, The First Affiliated Hospital of Ningbo University, No. 59, Liuting Street, Haishu District, Ningbo, 315000, Zhejiang, China.

Funding

The Key Research and Development Program of Ningbo 2023Z177the Medical Science and Technology Project of Zhejiang Province 2020KY819 and 2022KY1105

6 · The paper itself

Abstract

purposeTo examine the relationship between serum intact parathyroid hormone (iPTH) levels and survival in maintenance dialysis patients.

methodsWe retrospectively reviewed the data of patients who began and continued dialysis from January 2013 to December 2022. Patients were categorized based on their baseline and time-averaged (TA) iPTH levels into three groups: low (iPTH < 150 pg/ml), medium (150 ≤ iPTH < 300 pg/ml), and high (iPTH ≥ 300 pg/ml). We utilized the Kaplan-Meier method to assess survival differences, the Cox proportional hazards regression model to identify risk factors impacting adverse outcomes and the restricted cubic spline model to evaluate the association between iPTH levels and the all-cause mortality.

resultsWe included a total of 1023 participants, comprising 524 hemodialysis and 499 peritoneal dialysis. Kaplan-Meier analysis showed that high baseline group had higher survival and low baseline group had poorer survival, compared with medium baseline group, respectively (χ

conclusionThe survival for maintenance dialysis patients varies significantly based on their baseline and time-averaged iPTH levels, with time-averaged iPTH emerges as an independent risk factor for all-cause death in these patients.

Indexed as

Kidney Failure, ChronicParathyroid HormoneRenal DialysisAdultAgedFemaleHumansMaleMiddle AgedRetrospective StudiesSurvival RateParathyroid HormoneDialysis; Intact parathyroid hormone; Survival

Identifiers

PMID39557805

DOI10.1007/s11255-024-04288-y

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.